• Bactroban
• Bactroban Nasal Ointment summary of product characteristics
  
• Bactroban Nasal Ointment patient information leaflet
  
• Bactroban Ointment summary of product characteristics
  
• Bactroban Ointment patient information leaflet
  
• CUG=false
  
• tier=3

 

• Becotide
• Becotide Evohaler 50mcg summary of product characteristics
  
• Becotide Evohaler 50mcg patient information leaflet
  
• Becotide Evohaler 100mcg Summary of product characteristics
  
• Becotide Evohaler 100mcg patient information leaflet
  
• Becotide Evohaler 250mcg summary of product characteristics
  
• Becotide Evohaler 250mcg patient information leaflet
  
• CUG=false
• tier=3

 

• Benlysta
• Summary of product characteristics
  
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Betnovate
• Betnovate Cream 0.1% w/w summary of product characteristics
  
• Betnovate Cream 0.1% w/w patient information leaflet
  
• Betnovate Oinment 0.1% w/w summary of product characteristics
  
• Betnovate Oinment 0.1% w/w patient information leaflet
  
• Betnovate Scalp Application 0.1% w/v Cutaneous Solution summary of product characteristics
  
• Betnovate Scalp Application 0.1% w/v Cutaneous Solution patient information leaflet
  
• CUG=false
• tier=3

 

• Boostrix
• Summary of product characteristics
  
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Boostrix IPV
• Summary of product characteristics
  
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Celsentri
• Summary of product characteristics
  
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Cervarix
• European public assessment report
• Summary of product characteristics
  
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Combivir
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Dermovate
• Dermovate Ointment 0.05% summary of product characteristics
  
• Dermovate Ointment 0.05% patient information leaflet
  
• Dermovate Cream 0.05% summary of product characteristics
  
• Dermovate Cream 0.05% patient information leaflet
  
• Dermovate Scalp Application 0.05% w/v Cutaneous Solution summary of product characteristics
  
• Dermovate Scalp Application 0.05% w/v Cutaneous Solution patient information leaflet
  
• CUG=false
• tier=3

T

 

• Dectova▼
  
• Summary of product characteristics
  
• Patient Information Leaflet
  
• CUG=false
• tier=3

 

• Engerix-B
• Summary of Product Characteristics
• Patient Information Leaflet
• CUG=false
• tier=3
  
   

• Epivir
• Epivir Film-Coated Tablets 300mg summary of product characteristics
  
• Epivir Film-Coated Tablets 300mg patient information leaflet
  
• Epivir Oral Solution 10mg/ml summary of product characteristics
  
• Epivir Oral Solution 10mg/ml patient information leaflet
  
• Epivir Film-Coated Tablets 150mg summary of product characteristics
  
• Epivir Film-Coated Tablets 150mg patient information leaflet
  
• CUG=false
• tier=3

 

• Eumovate
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Flixotide
• Flixotide Diskus 500mcg summary of product characteristics
  
• Flixotide Diskus 500mcg patient information leaflet
  
• Flixotide Diskus 250mcg summary of product characteristics
  
• Flixotide Diskus 250mcg patient information leaflet
  
• Flixotide Diskus 100mcg summary of product characteristics
  
• Flixotide Diskus 100mcg patient information leaflet
  
• Flixotide Diskus 50mcg summary of product characteristics
  
• Flixotide Diskus 50mcg patient information leaflet
  
• Flixotide Evohaler 250mcg summary of product characteristics
  
• Flixotide Evohaler 250mcg patient information leaflet
  
• Flixotide Evohaler 125mcg summary of product characteristics
  
• Flixotide Evohaler 125mcg patient information leaflet
  
• Flixotide Evohaler 50mcg summary of product characteristics
  
• Flixotide Evohaler 50mcg patient information leaflet
  
• CUG=false
• tier=3

 

• Fortum
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Hiberix
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Infanrix Hexa
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Integrilin
• Integrilin 2 mg/ml solution for injection summary of product characteristics
  
• Integrilin 2 mg/ml solution for injection patient information leaflet
  
• Integrilin 0.75 mg/ml solution for injection summary of product characteristics
  
• Integrilin 0.75 mg/ml solution for injection patient information leaflet
  
• CUG=false
• tier=3

 

• Jemperli
• Summary of product characteristics
  
• Patient information leaflet
  
• Patient Alert Card
  
• CUG=false
• tier=3

 

• Juluca
• Summary of product characteristics
  
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Kivexa
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Lyclear
• Lyclear Dermal Cream summary of product
• Lyclear Dermal Cream summary of product
  
• CUG=false
• tier=3

 

• Malarone
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Menjugate
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Phymet
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Rekambys
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Requip
• Requip 0.25 mg film-coated tablets summary of product characteristics
• Requip 0.25 mg film-coated tablets patient information leaflet
• Requip 1 mg film-coated tablets summary of product characteristics
• Requip 1 mg film-coated tablets patient information leaflet
• Requip 2 mg film-coated tablets summary of product characteristics
• Requip 2 mg film-coated tablets patient information leaflet
• Requip 5 mg film-coated tablets summary of product characteristics
• Requip 5 mg film-coated tablets patient information leaflet
• CUG=false
• tier=3

 

• Requip-Modutab
• Requip-Modutab 2 mg prolonged-release tablets summary of product characteristics
• Requip-Modutab 2 mg prolonged-release tablets patient information leaflet
• Requip-Modutab 4 mg prolonged-release tablets summary of product characteristics
• Requip-Modutab 4 mg prolonged-release tablets patient information leaflet
• Requip-Modutab 8 mg prolonged-release tablets summary of product characteristics
• Requip-Modutab 8 mg prolonged-release tablets patient information leaflet
• CUG=false
• tier=3

 

• Retrovir
• Retrovir Capsules 100mg summary of product characteristics
• Retrovir Capsules 100mg patient information leaflet
• Retrovir IV summary of product characteristics
• Retrovir IV patient information leaflet
• Retrovir Oral Solution summary of product characteristics
• Retrovir Oral Solution patient information leaflet
• CUG=false
• tier=3

 

• Seroxat
• Seroxat 10mg Tablets summary of product characteristics
• Seroxat 10mg Tablets patient information leaflet
• Seroxat 20mg Tablets summary of product characteristics
• Seroxat 20mg Tablets patient information leaflet
• Seroxat 30mg Tablets summary of product characteristics
• Seroxat 30mg Tablets patient information leaflet
• CUG=false
• tier=3

 

• Stieprox
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Telzir
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Trizivir
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Valtrex
• Valtrex 250 mg film-coated tablets summary of product characteristics
• Valtrex 250 mg film-coated tablets patient information leaflet
• Valtrex 500 mg film-coated tablets summary of product characteristics
• Valtrex 500 mg film-coated tablets patient information leaflet
• CUG=false
• tier=3

 

• Vocabria
• Summary of product characteristics
• Patient information leaflet
  
• View details
• CUG=false
• tier=1

 

• Vocabria
• Summary of product characteristics
• Patient information leaflet
  
• View details
• CUG=false
• tier=1

 

• Zantac
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Zeffix
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Zejula 100mg Capsules
• Summary of product characteristics
• Patient information leaflet
  
• View details
• CUG=false
• tier=1

 

• Zejula 100mg Film Coated Tablet
• Summary of product characteristics
• Patient information leaflet
  
• View details
• CUG=false
• tier=1

 

• Ziagen
• Ziagen Oral Solution 20mg/ml summary of product characteristics
• Ziagen Oral Solution 20mg/ml patient information leaflet
• Ziagen Film-Coated Tablets 300mg summary of product characteristics
• Ziagen Film-Coated Tablets 300mg patient information leaflet
• CUG=false
• tier=3

 

• Zinacef
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Zinnat
• Summary of product characteristics
• Patient information leaflet
  
• CUG=false
• tier=3

 

• Zovirax
• Zovirax 800mg Dispersible Tablets Summary of Product Characteristics
• Zovirax 800mg Dispersible Tablets Patient information leaflet
  
• Zovirax Double Strength Suspension Summary of Product Characteristics
  
• Zovirax Double Strength Suspension Patient information leaflet
• Zovirax 200mg Dispersible Tablets Summary of Product Characteristics
• Zovirax 200mg Dispersible Tablets Patient information leaflet
  
• Zovirax 5% w/w Cream Summary of Product Characteristics
• Zovirax 5% w/w Cream Patient information leaflet
• Zovirax 200mg/5 ml Oral Suspension Summary of Product Characteristics
• Zovirax 200 mg/5 ml Oral Suspension Patient information leaflet
• Zovirax IV 250mg Summary of Product Characteristics
• Zovirax IV 250mg Patient information leaflet
• CUG=false
• tier=3